ANGPT2 and acute respiratory distress syndrome: In our high-risk cohort (mean LIPS, 5 ± 2.5), the plasma sRAGE was particularly adept at ARDS prediction, with better test characteristics than LIPS or a biomarker (Ang-2) when used in a population of unselected ICU patients8.